This inventor holds 1 USPTO granted patent. Top assignees: Massachusetts Institute of Technology, The General Hospital Corporation. Active years: 2022.
Company Filing History:
1 out of 8,576 
1 out of 3,070 
Years Active: 2022
Title: Alessandro Angelini: Innovator in Chemokine Research
Introduction
Alessandro Angelini is a notable inventor based in Lavagno, Italy. He has made significant contributions to the field of chemokine research, particularly through his innovative patent work. His expertise and dedication to scientific advancement have positioned him as a key figure in his area of specialization.
Latest Patents
Alessandro holds a patent for "Multiple specificity binders of CXC chemokines." This patent provides for fusion proteins comprising multispecific variable regions that bind more than one ELR+ CXC chemokine. His work in this area has the potential to impact therapeutic approaches in various medical fields.
Career Highlights
Throughout his career, Alessandro has worked with prestigious institutions, including the Massachusetts Institute of Technology and The General Hospital Corporation. His experience in these renowned organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.
Collaborations
Alessandro has collaborated with notable colleagues such as Karl Dane Wittrup and Andrew David Luster. These partnerships have further enriched his research and innovation efforts.
Conclusion
Alessandro Angelini's contributions to chemokine research through his patent and collaborations highlight his role as an influential inventor in the scientific community. His work continues to pave the way for advancements in medical research and therapeutic applications.